Summary of Study ST002600

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001020. The data can be accessed directly via it's Project DOI: 10.21228/M8V97D This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002600
Study TitleMoTrPAC: Endurance exercise training study in young adult rats, Tissue:Heart - Targeted Keto Acids
Study SummaryThe goal of the endurance exercise training study in young adult rats (internal code: PASS1B-06) was to perform exercise training studies in adult (6 month) F344 rats, and from these rats collect as many tissues as feasible in order to provide high quality samples for detailed analysis by chemical analysis sites. Tissues were collected from 10-12 rats sedentary control rats concurrent with the collection of the 8-week training groups. The 8-week training group and controls were from the same cohort and same age at euthanasia (either 8). For the older age group, an additional set of controls (n=5-6) were collected with the 1-2 week training group. Rats were either sedentary or underwent an exercise training program. Rats were exercised on the rodent treadmill 5 days per week using a progressive training protocol designed to exercise the rats at approximately 70% of VO2max as outlined in the Table on the next page. Training was performed no earlier than 10:00 am and no later than 5:00 pm over 5 consecutive days per week. Training was initiated with the treadmill set at 70% of VO2 max (see tables) and 5 degrees grade for 20 minutes. The duration of exercise was increased by one minute each day until day 31 of training (start of week 7), when a duration of 50 min was reached. Speed and grade of each training session increased in larger increments due to treadmill parameters. The highest intensity and duration of training began on day 31. This intensity was maintained for the final 10 days of the protocol to ensure steady state had been achieved. If any rats were unable to perform at least 4 days of training per week they were removed from the study and euthanized. It is important to note that the starting treadmill speed varied depending on the sex and age of the rat. The initial and maximum speeds were based on VO2max measurements obtained during the pre-training testing of the compliant rats. Rats assigned to the control group followed a schedule similar to the training group. They were placed in one lane on the treadmill for 15 minutes/day, 5 days per week. The treadmill was set at 0 m/min at an incline that corresponded to the incline being used by the training group.
Institute
Duke University
DepartmentDuke Molecular Physiology Institute
LaboratoryMetabolomics Core Laboratory
Last NameNewgard
First NameChristopher
Address300 N Duke St, Durham, NC 27701
Emailchris.newgard@duke.edu
Phone(919) 668-6059
Submit Date2023-04-28
Raw Data AvailableYes
Raw Data File Type(s)TBD
Analysis Type DetailMS
Release Date2023-10-06
Release Version1
Christopher Newgard Christopher Newgard
https://dx.doi.org/10.21228/M8V97D
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001020
Project DOI:doi: 10.21228/M8V97D
Project Title:MoTrPAC
Project Summary:MoTrPAC is a national research consortium designed to discover and perform preliminary characterization of the range of molecular transducers (the "molecular map") that underlie the effects of physical activity in humans. The program's goal is to study the molecular changes that occur during and after exercise and ultimately to advance the understanding of how physical activity improves and preserves health. Preclinical and clinical studies will examine the systemic effects of endurance and resistance exercise across a range of ages and fitness levels by molecular probing of multiple tissues before and after acute and chronic exercise. This program is the largest targeted NIH investment of funds into the mechanisms of how physical activity improves health and prevents disease. The MoTrPAC program is supported by the NIH Common Fund and is managed by a trans-agency working group representing multiple NIH institutes and centers, led by the NIH Office of Strategic Coordination, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, and National Institute of Biomedical Imaging and Bioengineering. MoTrPAC Steering Committee: Wendy Kohrt, Chair, Russ Tracy, Co-Chair; NIH Program Manager, Concepcion Nierras. Euan Ashley and Matthew Wheeler are the PIs for the Motrpac Bioinformatics / Data Coordination Center.
Institute:MoTrPAC
Last Name:Ashley
First Name:Euan
Address:Falk Building CV267, 870 Quarry Road, Stanford, California 94305
Email:motrpac-data-deposition@lists.stanford.edu
Phone:(650) 725-1846

Subject:

Subject ID:SU002702
Subject Type:Mammal
Subject Species:Rattus norvegicus
Taxonomy ID:10116

Factors:

Subject type: Mammal; Subject species: Rattus norvegicus (Factor headings shown in green)

mb_sample_id local_sample_id Group Timepoint Sex
SA26001590248015810Control 8 weeks of training or control time Female
SA26001690252015810Control 8 weeks of training or control time Female
SA26001790266015810Control 8 weeks of training or control time Female
SA26001890265015810Control 8 weeks of training or control time Female
SA26001990245015810Control 8 weeks of training or control time Female
SA26002090237015810Control 8 weeks of training or control time Male
SA26002190239015810Control 8 weeks of training or control time Male
SA26002290229015810Control 8 weeks of training or control time Male
SA26002390217015810Control 8 weeks of training or control time Male
SA26002490232015810Control 8 weeks of training or control time Male
SA26002580022815818_3QC-ExternalStandard 0 hour -
SA26002680022815818_1QC-ExternalStandard 0 hour -
SA26002780023825818_3QC-ExternalStandard 0 hour -
SA26002880022815818_4QC-ExternalStandard 0 hour -
SA26002980023825818_2QC-ExternalStandard 0 hour -
SA26003080022815818_2QC-ExternalStandard 0 hour -
SA26003180023825818_4QC-ExternalStandard 0 hour -
SA26003280023825818_1QC-ExternalStandard 0 hour -
SA26003390567015810Training 1 week of training or control time Female
SA26003490560015810Training 1 week of training or control time Female
SA26003590571015810Training 1 week of training or control time Female
SA26003690564015810Training 1 week of training or control time Female
SA26003790559015810Training 1 week of training or control time Female
SA26003890421015810Training 1 week of training or control time Male
SA26003990423015810Training 1 week of training or control time Male
SA26004090430015810Training 1 week of training or control time Male
SA26004190426015810Training 1 week of training or control time Male
SA26004290422015810Training 1 week of training or control time Male
SA26004390585015810Training 2 weeks of training Female
SA26004490587015810Training 2 weeks of training Female
SA26004590581015810Training 2 weeks of training Female
SA26004690576015810Training 2 weeks of training Female
SA26004790578015810Training 2 weeks of training Female
SA26004890449015810Training 2 weeks of training Male
SA26004990441015810Training 2 weeks of training Male
SA26005090439015810Training 2 weeks of training Male
SA26005190450015810Training 2 weeks of training Male
SA26005290444015810Training 2 weeks of training Male
SA26005390406015810Training 4 weeks of training Female
SA26005490420015810Training 4 weeks of training Female
SA26005590410015810Training 4 weeks of training Female
SA26005690412015810Training 4 weeks of training Female
SA26005790416015810Training 4 weeks of training Female
SA26005890280015810Training 4 weeks of training Male
SA26005990281015810Training 4 weeks of training Male
SA26006090283015810Training 4 weeks of training Male
SA26006190289015810Training 4 weeks of training Male
SA26006290292015810Training 4 weeks of training Male
SA26006390258015810Training 8 weeks of training or control time Female
SA26006490259015810Training 8 weeks of training or control time Female
SA26006590267015810Training 8 weeks of training or control time Female
SA26006690254015810Training 8 weeks of training or control time Female
SA26006790251015810Training 8 weeks of training or control time Female
SA26006890225015810Training 8 weeks of training or control time Male
SA26006990218015810Training 8 weeks of training or control time Male
SA26007090222015810Training 8 weeks of training or control time Male
SA26007190227015810Training 8 weeks of training or control time Male
SA26007290223015810Training 8 weeks of training or control time Male
Showing results 1 to 58 of 58

Collection:

Collection ID:CO002695
Collection Summary:-
Sample Type:Heart

Treatment:

Treatment ID:TR002714
Treatment Summary:-

Sample Preparation:

Sampleprep ID:SP002708
Sampleprep Summary:10 µl of plasma or 300 µl of tissue homogenate prepared at 100 mg/ml in 3M perchloric acid containing isotopically labeled internal standards KIC-d3, KIV-5C13, (Cambridge Isotope Laboratories), and KMV-d8 (Toronto Research Chemicals) are precipitated with 150 µl of 3M PCA. 200 µl of 25 M o-phenylenediamine (OPD) in 3M HCl is added to the supernatants and the samples are incubated at 80oC for 20 minutes. Keto acids are extracted with ethyl acetate. The extracts are dried under nitrogen and reconstituted in 200 mM ammonium acetate.
Sampleprep Protocol Filename:pass1b_experimental_design_metabolomics.pdf

Combined analysis:

Analysis ID AN004272
Analysis type MS
Chromatography type Reversed phase
Chromatography system Waters Acquity UPLC
Column Waters Acquity UPLC BEH C18 (50 x 2.1 mm,1.7 um)
MS Type MRM
MS instrument type Triple quadrupole
MS instrument name Waters Xevo TQ-S
Ion Mode POSITIVE
Units pmol/mg of tissue

Chromatography:

Chromatography ID:CH003178
Chromatography Summary:The analytical column is used at 30°C. 10 µl of the sample are injected onto the column and eluted at a flow rate of 0.4 ml/min. The gradient begins with 45% eluent A (5 mM ammonium acetate in water) and is then programmed as follows: 0 to 2 min – gradient to 55% eluent B (methanol); 2 to 2.5 min - gradient to 95% eluent B; 2.5 to 3.2 min - hold at 95% eluent B, return to 45% A, and re-equilibrate the column at initial conditions for 1 minute.
Methods Filename:pass1b_ka_methods.pdf
Instrument Name:Waters Acquity UPLC
Column Name:Waters Acquity UPLC BEH C18 (50 x 2.1 mm,1.7 um)
Column Temperature:30C
Flow Gradient:45% A and 55% B for 2 minutes, followed by a linear gradient to 95% B from 2 to 2.5 minutes, held at 95% B for 0.7 minutes, returned to 45% A, and finally the column was re-equilibrated at initial conditions for 1 minute. The total run time was 4.7 minutes.
Flow Rate:0.4 ml/min
Solvent A:100% water; 5 mM ammonium acetate
Solvent B:100% methanol
Chromatography Type:Reversed phase

MS:

MS ID:MS004019
Analysis ID:AN004272
Instrument Name:Waters Xevo TQ-S
Instrument Type:Triple quadrupole
MS Type:MRM
MS Comments:Mass transitions of m/z 203 -> 161 (ketoleucine or KIC), 206 -> 161 (KIC-d3), 189 -> 174 (ketoisovalerate or KIV), 194 -> 178 (KIV-5C13), 203 -> 174 (3-methyl-2-oxovalerate or KMV), and 211 -> 177 (KMV-d8) are monitored in a positive ion electrospray ionization mode.
Ion Mode:POSITIVE
  logo